Cervical cancer often affects young women, with about 9,000 diagnosed each year and about 2,000 to 3,000 dying.The main cause of cervical cancer is HPV infection, and HPV vaccination is expected to reduce about 6% of cervical cancer, but since June 2013, it has been actively recommended by the Ministry of Health, Labor and Welfare. Due to the temporary withholding, the inoculation is almost stopped.

　If the active recommendation of the Ministry of Health, Labor and Welfare is resumed, the negative effects of the temporary withholding of the active recommendation of the HPV vaccine (increased risk of cervical cancer) will be reduced, and the re-dissemination of the HPV vaccine will be issues.Therefore, Dr. Ueda and his colleagues summarized and announced measures to deal with the challenges faced when the active recommendation of the HPV vaccine is resumed in the future.

　Recommendations include vaccination-related content such as "to forgo vaccination and inoculate girls over the target age" and "to inoculate boys of the same age as girls who have forgotten the HPV vaccine" and "cervical cervix". Information and awareness regarding information and awareness such as "Reducing health hazards due to temporary withholding of active recommendation by encouraging cancer screening" and "Re-spreading vaccines by encouraging vaccination using behavioral economic methods" It consists of contents.

　In the future, when the Ministry of Health, Labor and Welfare resumes active recommendation, it is expected that the incidence of cervical cancer in women in Japan will decrease by taking these measures.

Paper information:[Lancet Oncology] Beyond Resumption of Japan's Governmental Recommendation of the HPV Vaccine